<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04094558</url>
  </required_header>
  <id_info>
    <org_study_id>19-0957</org_study_id>
    <nct_id>NCT04094558</nct_id>
  </id_info>
  <brief_title>Validation of Ingestible Capsule to Study Small Bowel</brief_title>
  <official_title>Validation of Ingestible Capsule to Study Small Bowel</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Calgary</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Calgary</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Proof of concept study to validate the ability of the ingestible capsule to gather samples
      from the small bowel for microbiome analysis in adults.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2020</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bacterial density count</measure>
    <time_frame>same 1 day</time_frame>
    <description>density count and comparison between capsule and stool sample (CFU/ml)</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">22</enrollment>
  <condition>Proof of Concept</condition>
  <arm_group>
    <arm_group_label>Single Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participant swallows and retrieves capsule in stool. Capsule and stool samples are analyzed for bacterial density and composition.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ingestible capsule</intervention_name>
    <description>Participants will swallow capsule and undergo X-rays to establish transit.</description>
    <arm_group_label>Single Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Aged between 18 and 70 years

          2. Diagnosis of IBS by Rome 4 criteria (Group 1) or no previous diagnosis of IBS or
             suspected IBS (Group 2)

          3. Ability to understand and provide informed consent

          4. Ability and willingness to meet the required schedule and study interventions

          5. Adequate mobility to transfer repeatedly between X-ray (standing), US (lying), and
             waiting (sitting)

        Exclusion Criteria:

          1. Prior gastrointestinal surgery which has altered the anatomy of the esophagus, stomach
             or small or large intestine (exceptions include appendectomy or cholecystectomy more
             than 3 months prior to enrollment).

          2. Use of any medications in the previous week that could substantially alter
             gastrointestinal motor function (e.g. opioids, prokinetics, anticholinergics,
             laxatives), or acidity (PPI, H2RA)

          3. Body Mass Index (BMI) &gt; 38.

          4. Previous history of gastric bezoar or gastroparesis.

          5. Any abdominal or pelvic surgery within the past 3 months.

          6. Known history of inflammatory bowel disease.

          7. History of diverticulitis, diverticular stricture, or other intestinal strictures.

          8. History of abdominal or pelvic radiotherapy

          9. History of dysphagia, eosinophilic esophagitis, esophageal stricture, or other
             swallowing disorder

         10. Females of childbearing age who are not practicing birth control and/or are pregnant
             or lactating

         11. Cardiovascular, endocrine, renal or other chronic disease likely to affect motility.

         12. No colon cleansing prep for 1 month

         13. No antibiotics or probiotics for 2 weeks

         14. &lt; 2 bowel movements per week
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lynn Wilsack, MSc</last_name>
    <phone>403 592-5045</phone>
    <email>lwilsack@ucalgary.ca</email>
  </overall_contact>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 17, 2019</study_first_submitted>
  <study_first_submitted_qc>September 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 19, 2019</study_first_posted>
  <last_update_submitted>March 24, 2020</last_update_submitted>
  <last_update_submitted_qc>March 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

